Bertha Brodin

7.8k total citations
33 papers, 1.2k citations indexed

About

Bertha Brodin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Bertha Brodin has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Bertha Brodin's work include Sarcoma Diagnosis and Treatment (13 papers), RNA Interference and Gene Delivery (5 papers) and Immunotherapy and Immune Responses (4 papers). Bertha Brodin is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), RNA Interference and Gene Delivery (5 papers) and Immunotherapy and Immune Responses (4 papers). Bertha Brodin collaborates with scholars based in Sweden, United States and United Kingdom. Bertha Brodin's co-authors include Olle Larsson, Yuntao Xie, Katarina Le Blanc, Gunnar Nilsson, Pádraig D’Arcy, Björn Skytting, Fabrício F. Costa, Joakim Lundeberg, Monika Ehnman and Armando Bartolazzi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, ACS Nano and PLoS ONE.

In The Last Decade

Bertha Brodin

32 papers receiving 1.2k citations

Peers

Bertha Brodin

PRM

ONCOL

IMMUN

Kamalesh K. Sankhala United States

Emmy D.G. Fleuren Netherlands

Katharina Lückerath Germany

Ymera Pignochino Italy

Chuifeng Fan China

Chiara Spadazzi Italy

Andreas Zoephel Austria

Lana S. Grauer United States

Sara Cresta Italy

Janna Paulsson Sweden

Kamalesh K. Sankhala United States

Bertha Brodin

838 ×1.3

694 ×1.5

PRM

797 ×1.8

ONCOL

148 ×0.7

IMMUN

194 ×1.3

Citations per year, relative to Bertha Brodin Bertha Brodin (= 1×) peers Kamalesh K. Sankhala

Countries citing papers authored by Bertha Brodin

Since Specialization

Citations

This map shows the geographic impact of Bertha Brodin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertha Brodin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertha Brodin more than expected).

Fields of papers citing papers by Bertha Brodin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertha Brodin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertha Brodin. The network helps show where Bertha Brodin may publish in the future.

Co-authorship network of co-authors of Bertha Brodin

This figure shows the co-authorship network connecting the top 25 collaborators of Bertha Brodin. A scholar is included among the top collaborators of Bertha Brodin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertha Brodin. Bertha Brodin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brodin, Bertha, et al.. (2025). Innate immuno-response to nanoparticle uptake in liver and spleen mimics pathogen infection. Nanomedicine. 20(22). 2721–2731.

Liaño-Pons, Judit, Jiansheng Wang, Mohammad Alzrigat, et al.. (2024). EZH2 inhibition sensitizes retinoic acid-driven senescence in synovial sarcoma. Cell Death and Disease. 15(11). 836–836. 1 indexed citations

Brodin, Bertha, et al.. (2024). Laboratory Liquid-Jet X-ray Microscopy and X-ray Fluorescence Imaging for Biomedical Applications. International Journal of Molecular Sciences. 25(2). 920–920. 4 indexed citations

Vogt, Carmen, et al.. (2023). Organ Uptake, Toxicity and Skin Clearance of Ruthenium Contrast Agents Monitored In Vivo by X-Ray Fluorescence. Nanomedicine. 18(18). 1161–1173. 6 indexed citations

Vogt, Carmen, Yuyang Li, Bertha Brodin, et al.. (2021). Optical and X-ray Fluorescent Nanoparticles for Dual Mode Bioimaging. ACS Nano. 15(3). 5077–5085. 32 indexed citations

Dyberg, Cecilia, Thale Kristin Olsen, Bertha Brodin, et al.. (2019). Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth. Cancers. 12(1). 73–73. 10 indexed citations

Brodin, Bertha, Krister Wennerberg, Elisabet Lidbrink, et al.. (2019). Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas. British Journal of Cancer. 120(4). 435–443. 25 indexed citations

Barrott, Jared J., Neal Poulin, Bertha Brodin, et al.. (2017). HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma. PLoS ONE. 12(1). e0169407–e0169407. 28 indexed citations

Ji, Jennifer X., et al.. (2016). Identification of cytotoxic agents disrupting synovial sarcoma oncoprotein interactions by proximity ligation assay. Oncotarget. 7(23). 34384–34394. 13 indexed citations

10.

Ma, Limin, Angela Strambi, Pádraig D’Arcy, et al.. (2014). SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth. Cell Death and Disease. 5(10). e1483–e1483. 31 indexed citations

11.

D’Arcy, Pádraig, et al.. (2014). Oncogenic Functions of the Cancer-Testis Antigen SSX on the Proliferation, Survival, and Signaling Pathways of Cancer Cells. PLoS ONE. 9(4). e95136–e95136. 40 indexed citations

12.

Ehnman, Monika, Edoardo Missiaglia, Erika Folestad, et al.. (2013). Distinct Effects of Ligand-Induced PDGFRα and PDGFRβ Signaling in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Compartments. Cancer Research. 73(7). 2139–2149. 73 indexed citations

13.

D’Arcy, Pádraig, et al.. (2009). Reactivation of p53 function in synovial sarcoma cells by inhibition of p53–HDM2 interaction. Cancer Letters. 275(2). 285–292. 19 indexed citations

14.

Xie, Yuntao, Ada Girnita, Pádraig D’Arcy, et al.. (2008). Differential roles of SS18–SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth. Biochemical and Biophysical Research Communications. 368(3). 793–800. 23 indexed citations

15.

D’Arcy, Pádraig, et al.. (2008). The Oncoprotein SS18-SSX1 Promotes p53 Ubiquitination and Degradation by Enhancing HDM2 Stability. Molecular Cancer Research. 6(1). 127–138. 26 indexed citations

16.

Costa, Fabrício F., Katarina Le Blanc, & Bertha Brodin. (2006). Concise Review: Cancer/Testis Antigens, Stem Cells, and Cancer. Stem Cells. 25(3). 707–711. 110 indexed citations

17.

Wejde, Johan, et al.. (2004). A Novel Case of Synovial Sarcoma of the Kidney: Impact of SS18/SSX Analysis of Renal Hemangiopericytoma-like Tumors. Diagnostic Molecular Pathology. 13(1). 47–51. 25 indexed citations

18.

Brodin, Bertha, et al.. (2002). A Novel Type of SYT/SSX Fusion: Methodological and Biological Implications. Modern Pathology. 15(6). 679–685. 23 indexed citations

19.

Brodin, Bertha, Karl Haslam, Ke Yang, et al.. (2001). Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression. Gene. 268(1-2). 173–182. 47 indexed citations

20.

Avila‐Cariño, Javier, Nongnit Lewin, Katsuhiko Yamamoto, et al.. (1994). EBV infection of B-CLL cellsin vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype. International Journal of Cancer. 58(5). 678–685. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact